Needham upgraded Acadia Pharmaceuticals to Buy from Hold with a $37 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACAD:
- Acadia Pharmaceuticals price target raised to $40 from $35 at Mizuho
- ‘Time to Pull the Trigger,’ Says Morgan Stanley About These 2 Healthcare Stocks
- Largest borrow rate increases among liquid names
- Acadia Pharmaceuticals upgraded to Overweight from Equal Weight at Morgan Stanley
- Biotech Alert: Searches spiking for these stocks today